News FDA bans red dye used in medicines over cancer risk The FDA has banned the use of a red dye used in oral medicines, foods and dietary supplements, more than 30 years after it was linked to cancer.
Partner Content Partner Content Highly Potent Active Pharmaceutical Ingredients Conference H... SMi's 2nd annual HPAPI Conference
Partner Content Partner Content Exclusive Interview Released with HPAPI Project Services SMi's 2nd Annual HPAPI 2018 Conference
Partner Content Partner Content Hear from Genentech and Cristalia Produtos Quimicos Farmaceu... HPAPI 2018
News UK's long-term R&D investment policy welcomed The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.